Carnozin SF Syrup

Carnozin SF Syrup is a prescription medicine used in the treatment of ulcers in the stomach and intestine. It forms a coating over ulcers and creates a physical barrier thereby promotes healing of ulcer.

Carnozin SF Syrup can be taken with or without food, but remember to take it at a fixed time each day for better efficacy . You should keep taking this medicine for as long as your doctor recommends. If you stop treatment too early your symptoms may come back and your condition may worsen. Let your doctor know about all other medications you are taking as some may affect, or be affected by this medicine.

The most common side effects of this medicine are constipation, so it is better to take plenty of fluids while taking this medicine to avoid side effects. Dizziness and sleepiness may also occur, so do not drive or do anything that requires mental focus until you know how this medicine affects you.

Before taking this medicine it is better to inform the doctor if you are suffering from any liver or kidney disease as a dose of your medicine needs to be adjusted. It is better to not take this medicine along with an antacid, you may try to take it two hours before or after taking this medicine.

• Peptic ulcer disease

Peptic ulcer disease
Peptic ulcer disease is a condition in which painful sores or ulcers develop in the inner lining of the stomach or gut (intestine). Carnozin SF Syrup reduces the amount of acid your stomach makes which prevents further damage to the ulcer as it heals naturally. You may be given other medicines along with this medicine depending on what caused the ulcer. You need to keep taking the medicine as it is prescribed for it to be effective, even if the symptoms seem to disappear.

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Carnozin

• Constipation

Take this medicine in the dose and duration as advised by your doctor. Check the label for directions before use. Measure it with a measuring cup and take it by mouth. Shake well before use. Carnozin SF Syrup may be taken with or without food, but it is better to take it at a fixed time.

Carnozin SF Syrup is a combination of two medicines: Sucralfate and Zinc Carnosine. Sucralfate forms a coating over the ulcer or any other raw surface. This creates a physical barrier that protects the ulcer/raw surface from the gastric acid or any other injury, allowing it to heal. Carnozin SF Syrup provides essential nutrients. This is it works to treat peptic ulcer disease.

• Carnozin SF Syrup is used in the treatment of peptic ulcer disease.
• Do not take other indigestion remedies (antacids) without consulting your doctor.
• Do not take Carnozin SF Syrup at least 2 hours before or after taking other medicines as it may interact with other medicines.
• Avoid smoking as it increases the risk of peptic ulcers and delays healing.
• It may take 2 to 8 weeks before you receive the full benefit of taking this medicine.
• Drink 6 to 8 full glasses of water daily to help prevent constipation while you are taking this medicine. Do not use a stool softener (laxative) without first asking your doctor.

Nishizawa T, Suzuki H, Kanai T, et al. Proton pump inhibitor alone vs proton pump inhibitor plus mucosal protective agents for endoscopic submucosal dissection-induced ulcer: A systematic review and meta-analysis. J Clin Biochem Nutr. 2015;56(2):85-90. [Accessed 01 Apr. 2020] (online) Available from:

McQuaid KR. Drugs Used in the Treatment of Gastrointestinal Diseases. In: Katzung BG, Masters SB, Trevor AJ (Editors). Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 1067-1101.

Hoogerwerf WA, Pasricha PJ. Pharmacotherapy of Gastric Acidity, Peptic Ulcers, and Gastroesophageal Reflux Disease. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. New York, New York: McGraw-Hill Medical; 2011. pp. 967-981.